Intronic miRNA-641 controls its host Gene's pathway PI3K/AKT and this relationship is dysfunctional in glioblastoma multiforme.

作者: Ludwig Christian Hinske , Jens Heyn , Max Hübner , Jessica Rink , Simon Hirschberger

DOI: 10.1016/J.BBRC.2017.05.175

关键词:

摘要: MicroRNAs have established their role as important regulators of the epigenome. A considerable number human miRNA genes are found in intronic regions protein-coding host genes, many cases adopting regulatory circuitry. However, emerging evidence foreshadows an unprecedented importance for this relationship: Intronic miRNAs may protect cell from overactivation respective pathway, a setting that trigger tumor development. AKT2 is well-known proto-oncogene central to PI3K/AKT pathway. This pathway known promote growth and survival, especially glioblastoma. Its miRNA, hsa-miR-641, scarcely investigated, however. We hypothesized miR-641 regulates its regulation become dysfunctional indeed expression differs significantly between GBM tissue normal brain samples, transfection glioma cells with antagonizes Combining clinical cultures, biomolecular methods, we could show doesn't affect AKT2's levels, but down-regulates kinases necessary AKT2-activation, thereby affecting functional state. also identified NFAT5 regulated factor these subsequently activate AKT2. In summary, our study first draws connecting line implication glioblastoma

参考文章(35)
Man-Su Kim, Leonid P. Shutov, Aswini Gnanasekaran, Zhihong Lin, Jacob E. Rysted, Jason D. Ulrich, Yuriy M. Usachev, Nerve Growth Factor (NGF) Regulates Activity of Nuclear Factor of Activated T-cells (NFAT) in Neurons via the Phosphatidylinositol 3-Kinase (PI3K)-Akt-Glycogen Synthase Kinase 3β (GSK3β) Pathway Journal of Biological Chemistry. ,vol. 289, pp. 31349- 31360 ,(2014) , 10.1074/JBC.M114.587188
D C Schmitt, L Madeira da Silva, W Zhang, Z Liu, R Arora, S Lim, A M Schuler, S McClellan, J F Andrews, A G Kahn, M Zhou, E-YE Ahn, M Tan, ErbB2 -intronic MicroRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling Cell Death and Disease. ,vol. 6, ,(2015) , 10.1038/CDDIS.2015.116
Yicheng Lu, Yong Cui, Jing Lin, Lei Zhang, Yan Dong, Guohan Hu, Chun Luo, Juxiang Chen, Jianling Zuo, AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo. OncoTargets and Therapy. ,vol. 8, pp. 1681- 1690 ,(2015) , 10.2147/OTT.S83795
Maria Mancini, Alex Toker, NFAT proteins: emerging roles in cancer progression Nature Reviews Cancer. ,vol. 9, pp. 810- 820 ,(2009) , 10.1038/NRC2735
Emmanuel Chautard, Zangbéwendé Guy Ouédraogo, Julian Biau, Pierre Verrelle, Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness Journal of Neuro-Oncology. ,vol. 117, pp. 205- 215 ,(2014) , 10.1007/S11060-014-1382-9
H. Dill, B. Linder, A. Fehr, U. Fischer, Intronic miR-26b controls neuronal differentiation by repressing its host transcript, ctdsp2 Genes & Development. ,vol. 26, pp. 25- 30 ,(2012) , 10.1101/GAD.177774.111
Simone Kreth, Niklas Thon, Sabina Eigenbrod, Juergen Lutz, Carola Ledderose, Rupert Egensperger, Joerg C. Tonn, Hans A. Kretzschmar, Ludwig C. Hinske, Friedrich W. Kreth, O6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0017156
Luni Emdad, Bin Hu, Swadesh K Das, Devanand Sarkar, Paul B Fisher, AEG-1-AKT2: A novel complex controlling the aggressiveness of glioblastoma. Molecular and Cellular Oncology. ,vol. 2, ,(2015) , 10.4161/23723556.2014.995008
Victoria A. Martin, Wen-Horng Wang, Andrew M. Lipchik, Laurie L. Parker, Yantao He, Sheng Zhang, Zhong-Yin Zhang, Robert L. Geahlen, Akt2 inhibits the activation of NFAT in lymphocytes by modulating calcium release from intracellular stores Cellular Signalling. ,vol. 24, pp. 1064- 1073 ,(2012) , 10.1016/J.CELLSIG.2012.01.001